Zymeworks (ZYME) Return on Sales (2021 - 2026)

Zymeworks has disclosed Return on Sales across 6 years of filings, most recently posting 0.18% for Q1 2026.

• Return on Sales for Q1 2026 came in at 0.18%, down 11.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.01% (up 1.0% YoY), and the FY2025 annual result was 0.01%, up 1.0% from the prior year.
• Return on Sales came in at 0.18% for Q1 2026 at Zymeworks, down from 0.16% in the prior quarter.
• In the past five years, Return on Sales ranged from a high of 0.01% in Q4 2022 to a low of 0.38% in Q1 2022.
• The 5-year median for Return on Sales is 0.03% (2024), against an average of 0.08%.
• Across the five-year window, Return on Sales soared 37 bps in 2023 and fell 16 bps in 2025, its largest moves.
• Zymeworks' Return on Sales stood at 0.01% in 2022, then tumbled by 190 bps to 0.01% in 2023, then gained by 11 bps to 0.01% in 2024, then slumped by 2063 bps to 0.16% in 2025, then declined by 12 bps to 0.18% in 2026.
• The last three Return on Sales figures came in at 0.18% (Q1 2026), 0.16% (Q4 2025), and 0.01% (Q3 2025), per Business Quant data.